... Zejula led to a longer PFS, meaning that cancer took longer to grow back. Zejula worked especially well for people who had a BRCA mutation. ...
... However, they recognized the importance of continuing to take their medication, despite side effects like weight gain: “I am glad that the Zejula is doing what it’s supposed to do.”Managing Weight Gain With Ovarian CancerAccording to the American Cancer Society and other cancer research, maintaining a healthy weight can reduce your risk of recurrence ...
Ovarian Cancer and Weight Gain
... However, they recognized the importance of continuing to take their medication, despite side effects like weight gain: “I am glad that the Zejula is doing what it’s supposed to do.”Managing Weight Gain With Ovarian CancerAccording to the American Cancer Society and other cancer research, maintaining a healthy weight can reduce your risk of recurrence ...
... There are currently three FDA-approved PARP inhibitors available: Niraparib (Zejula) Rucaparib (Rubraca) Olaparib (Lynparza) Each can be given to women with or without BRCA gene mutations. ...
... Drugs in this category that may be prescribed for ovarian cancer include Zejula (Niraparib), Lynparza (Olaparib), and Rubraca (Rucaparib).PARP inhibitors come in the form of pills or capsules. People who are prescribed these drugs typically take them once a day by mouth. ...
What To Expect From Ovarian Cancer Maintenance Treatment
... Drugs in this category that may be prescribed for ovarian cancer include Zejula (Niraparib), Lynparza (Olaparib), and Rubraca (Rucaparib).PARP inhibitors come in the form of pills or capsules. People who are prescribed these drugs typically take them once a day by mouth. ...
... PARP inhibitors are used as maintenance therapy after chemotherapy with a platinum-based drug and include: Niraparib (Zejula), which doesn’t require a biomarker Olaparib (Lynparza), used for cancers with BRCA1 or BRCA2 mutations Olaparib with bevacizumab, used for cancer cells with high genomic instability, with or without a BRCA mutation Rucaparib ...
Targeted Therapies for Ovarian Cancer: 8 New Treatments and Recent Advances
... PARP inhibitors are used as maintenance therapy after chemotherapy with a platinum-based drug and include: Niraparib (Zejula), which doesn’t require a biomarker Olaparib (Lynparza), used for cancers with BRCA1 or BRCA2 mutations Olaparib with bevacizumab, used for cancer cells with high genomic instability, with or without a BRCA mutation Rucaparib ...
... PARP inhibitors can block PARP without affecting healthy cells.PARP inhibitors available to treat ovarian cancer as of April 2025 include: Niraparib (Zejula) Olaparib (Lynparza) Rucaparib (Rubraca) PARP inhibitors are typically prescribed to be taken orally (by mouth) every day.Antibody-Drug ConjugatesAntibody-drug conjugates (ADCs) are a newer type ...
Platinum Resistance in Ovarian Cancer Treatment: What You Need To Know
... PARP inhibitors can block PARP without affecting healthy cells.PARP inhibitors available to treat ovarian cancer as of April 2025 include: Niraparib (Zejula) Olaparib (Lynparza) Rucaparib (Rubraca) PARP inhibitors are typically prescribed to be taken orally (by mouth) every day.Antibody-Drug ConjugatesAntibody-drug conjugates (ADCs) are a newer type ...
... Examples of PARP inhibitors include Lynparza (olaparib), Rubraca (rucaparib), and Zejula (niraparib).Testing for BRCA MutationsDoctors can find BRCA mutations through genetic testing. This process involves collecting a blood or saliva sample, which is sent to a laboratory. ...
BRCA Gene Mutations: What To Know About Ovarian Cancer Risk
... Examples of PARP inhibitors include Lynparza (olaparib), Rubraca (rucaparib), and Zejula (niraparib).Testing for BRCA MutationsDoctors can find BRCA mutations through genetic testing. This process involves collecting a blood or saliva sample, which is sent to a laboratory. ...
... This treatment helps prevent cancer from coming back or slows cancer growth.PARP inhibitors that may be used to treat ovarian cancer include: Olaparib (Lynparza) Niraparib (Zejula) Rucaparib (Rubraca) NTRK InhibitorsSome ovarian cancers have changes in NTRK genes. These genes cause cells to grow and divide. ...
6 Ovarian Cancer Treatment Options
... This treatment helps prevent cancer from coming back or slows cancer growth.PARP inhibitors that may be used to treat ovarian cancer include: Olaparib (Lynparza) Niraparib (Zejula) Rucaparib (Rubraca) NTRK InhibitorsSome ovarian cancers have changes in NTRK genes. These genes cause cells to grow and divide. ...
... PARP inhibitors include olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). PARP inhibitors make it harder for cancer cells to repair DNA damage, leaving them more vulnerable. ...
Recurrent Ovarian Cancer Explained
... PARP inhibitors include olaparib (Lynparza), niraparib (Zejula), and rucaparib (Rubraca). PARP inhibitors make it harder for cancer cells to repair DNA damage, leaving them more vulnerable. ...
... Drugs in the PARP inhibitor family include olaparib (Lynparza), rucaparib (Rubraca), and niraparib (Zejula).Mirvetuximab soravtansine-gynx (Elahere) is a newer targeted therapy option. This drug is a type of antibody drug conjugate. ...
Join
Your Privacy Choices
